Auteurs
Analysis
France
Racine
Analysis
France
Exploration
Accueil
Racine
Racine

Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Laurence Salin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Laurence Paire-Ficout < Laurence Salin < Laurent Cleret De Langavant  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 3.
Ident.Authors (with country if any)Title
000200 (2010) Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000217 (2010) Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
000322 (2007) Robert A. Hauser [États-Unis] ; Laurence Salin [France] ; Nolwenn Juhel [France] ; Victor L. Konyago [États-Unis]Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease

List of associated KwdEn.i

Nombre de
documents		Descripteur
3Aged
3Double-Blind Method
3Female
3Humans
3Male
3Middle Aged
3Nervous system diseases
3Parkinson Disease (drug therapy)
3Parkinson disease
3Parkinson's disease
2Antiparkinson Agents (administration & dosage)
2Antiparkinson Agents (adverse effects)
2Benzothiazoles (administration & dosage)
2Benzothiazoles (adverse effects)
2Delayed-Action Preparations (therapeutic use)
2Dopamine agonist
2Dose-Response Relationship, Drug
2Drug Administration Schedule
2Pramipexole
2Release
2Severity of Illness Index
2Treatment
2dopamine agonist
2treatment
1Antiparkinson Agents (therapeutic use)
1Benzothiazoles (therapeutic use)
1Bicyclo Compounds, Heterocyclic (therapeutic use)
1Clinical trial
1Confidence Intervals
1Delayed-Action Preparations (administration & dosage)
1Delayed-Action Preparations (adverse effects)
1Dopamine
1Evaluation
1Levodopa (therapeutic use)
1NS 2330
1Neurotransmitter Uptake Inhibitors (therapeutic use)
1Patient Satisfaction
1Quality of Life
1Retrospective Studies
1Reuptake inhibitor
1Safety
1Tesofensine
1Time Factors
1Treatment Outcome
1clinical trial
1dopamine reuptake inhibitor
1dopamine transporter
1monotherapy
1pramipexole extended release
1pramipexole‐extended release
1switch trial
1tesofensine

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Laurence Salin" 

HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Laurence Salin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Laurence Salin
}}
Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024